Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00355056 · ClinicalTrials.gov registry record · NA
PREMIUM Migraine Trial
A NA study, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 230
- Enrollment target
NCT00355056 is a NA study that has completed, run by Abbott Medical Devices. The registered enrollment target is 230 participants.
The verdict
NCT00355056, a NA study, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 230 participants
- Enrollment target
Study Summary
The Purpose of this study is to evaluate the impact of percutaneous closure of a patent foramen ovale (PFO) (a hole in the heart), using the AMPLATZER PFO Occluder, on the incidence of migraine headaches.
Interventions
- OTHER Sham Procedure
- DEVICE AMPLATZER PFO Occluder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 230 participants |
| Start Date | 2006-01 |
| Est. Completion | 2015-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00355056
The ClinicalTrials.gov registry entry for NCT00355056 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 230 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham Procedure is the first listed.
NCT00355056 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00355056 about?
NCT00355056 is a clinical study titled "PREMIUM Migraine Trial". The Purpose of this study is to evaluate the impact of percutaneous closure of a patent foramen ovale (PFO) (a hole in the heart), using the AMPLATZER PFO Occluder, on the incidence of migraine headaches.
What is the current status of trial NCT00355056?
This trial is currently completed. It is a NA study. The enrollment target is 230 participants. The study started on 2006-01. Estimated completion is 2015-12.
What interventions are being tested in trial NCT00355056?
The interventions under investigation include: Sham Procedure (OTHER), AMPLATZER PFO Occluder (DEVICE).
Who is sponsoring clinical trial NCT00355056?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.